Results 41 to 50 of about 4,977,677 (230)
Pembrolizumab in FIGO IVB Verrucous Carcinoma of the Vulva: A Case Report
Frontiers in Oncology, 2021 BackgroundVulvar cancer is the fourth most common gynecologic cancer, and prognosis is poor in advanced vulvar cancer patients. Treatment for advanced vulvar cancer has not been satisfactory.
Yuhan Wang +6 more
doaj +1 more source
European Journal of Nuclear Medicine and Molecular Imaging, 2021 This retrospective study aimed to assess the diagnostic performance of preoperative [18F]FDG-PET/CT in predicting the groin and pelvic lymph node (LN) status in a large single-centre series of vulvar cancer patients. Between January 2013 and October 2018,
V. Rufini +11 more
semanticscholar +1 more source
Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients
Diagnostics, 2021 Vulvar cancer incidence numbers have been rising steadily over the past decades. Especially the number of young patients with vulvar cancer increased recently.
Nadine Ansorge +10 more
doaj +1 more source
BMC Cancer, 2022 Background Incidence of cervical cancer has been reduced by organized screening while for vaginal and vulvar cancers no systematic screening has been implemented. All these cancers are associated with human papilloma virus (HPV) infection.
K. Hemminki +3 more
semanticscholar +1 more source
European Journal of Surgical Oncology (EJSO), 2006 The radical surgical approach in the treatment of vulvar cancer patients has led to a favorable prognosis for the majority of the patients with early stage squamous cell cancer. However, the morbidity is impressive, leading to more individualized treatment.
Hullu, J.A. de +3 more
openaire +3 more sources
Validation of the 2021 FIGO staging schema for advanced vulvar cancer
International Journal of Gynecological Cancer, 2022 Objective The International Federation of Gynecology and Obstetrics (FIGO) revised the vulvar cancer staging schema in 2021. Previous stage IIIA–B diseases were reclassified based on nodal size (≤5 mm for stage IIIA compared with >5 mm for stage IIIB ...
K. Matsuo +5 more
semanticscholar +1 more source
Patterns of recurrence and survival in vulvar cancer: A nationwide population-based study.
Gynecologic Oncology, 2021 OBJECTIVE To examine the patterns of recurrence and how these patterns are associated with survival in vulvar squamous cell carcinoma. We also explored the survival impact of surgical groin staging (SGS).
D. Zach +5 more
semanticscholar +1 more source
Journal of Obstetrics and Gynaecology, 2014 Vulvar cancer is an uncommon malignancy of the female genital tract in developing countries, accounting for 3% of gynaecological cancers. Here, cervical cancer is an everyday problem; ovarian cancer is the second commonest gynaecological cancer; endometrial is less common and vulvar cancer is rare.
S, Chhabra, M, Bhavani, A, Deshpande
openaire +2 more sources
Cancer Prevention Research, 2022 The human papillomavirus vaccine (HPV) was indicated for the prevention of vulvovaginal cancers in 2008, but its impact on the incidence of vulvar cancers within the US is unknown.
A. Berenson +4 more
semanticscholar +1 more source
Gynecologic Oncology, 2021 INTRODUCTION Sentinel lymph node biopsy (SLN) helps define lymph node status, a major prognostic factor in vulvar cancer. The aim of the current systematic review was to assess the use of indocyanine green (ICG) coupled with near-infrared (NIR ...
M. Koual +5 more
semanticscholar +1 more source